SII logo
SII logo
products

PRODUCTS SUPPLIED IN INDIA

Serum - Protection from birth onwards

Sicriptin

Bromocriptine Mesylate tablets I.P.

pharma

INDICATION

Inhibition/suppression of physiological lactation & Treatment of hyperprolactinaemic disorders

ROUTE OF ADMINISTRATION

Oral

DOSAGE

As directed by physician

COMPOSITION

  • Sicriptin 1.25 mg: Each uncoated tablet contain Bromocriptine Mesylate I.P. 1.435 mg (equal to 1.25 mg Bromocriptine base)
  • Sicriptin 2.5 mg: Each uncoated tablet contain Bromocriptine Mesylate I.P. 2.87 mg (equal to 2.5 mg Bromocriptine base)
PRESENTATION:
  • Sicriptin 1.25 mg: Box of 5 strips x 10 tablets
  • Sicriptin 2.5 mg: Box of 5 strips x 10 tablets